Savara announces new employment inducement grant

Austin, texas--(business wire)--savara inc. (nasdaq: svra), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the grant of inducement awards to three new employees. on august 3, 2023, the compensation committee of savara's board of directors granted the inducement awards to three new employees who recently joined the company. the inducement awards consist of options to purchase an aggregate of 150,000 shares of the company's common stock. these equ.
SVRA Ratings Summary
SVRA Quant Ranking